1
|
Zheng H, Zhao Y, Zhou H, Tang Y, Xie Z, Liu CJ. Mid-to-long term safety and efficacy of Woven EndoBridge device for Treatment of intracranial wide neck aneurysms: A systematic review and meta-analysis. Clin Neurol Neurosurg 2023; 232:107861. [PMID: 37423087 DOI: 10.1016/j.clineuro.2023.107861] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2023] [Revised: 06/19/2023] [Accepted: 06/24/2023] [Indexed: 07/11/2023]
Abstract
BACKGROUND In recent 10 years, Woven EndoBridge(WEB) device has been used as endovascular instrumentation for treating wide neck Bifurcation aneurysms. Its safety and efficacy in the mid-term (6-24 months) and long-term (more than 24 months) follow-up period have yet to be systematically reviewed. PURPOSE To evaluate the WEB device safety and efficacy, relevant literature and publications were extensively reviewed, and a meta-analysis was conducted. DATA RESOURCE All relevant literature/publications were achieved from Pubmed, Cochrane, Embase, and Web of Science databases. RESULTS 767 patients that were studied in 13 literature were included. The focus of this review was placed on the clinical and anatomic outcomes. Complete occlusion was achieved in 67.3% (95% CI, 59.0-75.5%) and 69.3% (95% CI, 55.7-82.8%) of the cases at mid- and long-term follow-up. The rate of adequate occlusion was 86.6% (95% CI, 83.0-90.2%) and 90.1% (95% CI, 85.5-94.4%) for the mid and long-term, respectively. 51 patients (8.8%; 95% CI,5.6-11.9%) and 18 (8.1%; 95% CI,0.8-15.5%) received retreatments during mid- and long-term follow-up, respectively. 410 patients from 427 (94.3%; 95% CI, 89.7-98.9%) showed favorable clinical outcomes. The all-cause mortality rate was 3.5% (95% CI, 1.4-5.6%), where only a few cases were related to the WEB implantation. The WEB device deployment was associated with an overall clinical complication rate of 4.1% (95% CI, 2.7-6.6%), 3 hemorrhagic (1.2%; 95% CI, 0.2-2.6%), and 30 thromboembolic (4.0%; 95% CI, 4.0- 6.0%) complications. CONCLUSIONS The findings reveal the satisfactory safety and effectiveness of the WEB device for the Treatment of wide-neck aneurysms during mid-to-long-term follow-up, indicating the high potential of the WEB device for wide application.
Collapse
Affiliation(s)
- Hui Zheng
- Department of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing 404100, China
| | - Yutong Zhao
- Department of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing 404100, China
| | - Hai Zhou
- Department of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing 404100, China
| | - Yuguang Tang
- Department of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing 404100, China
| | - Zongyi Xie
- Department of Neurosurgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing 404100, China.
| | - Cheng Jiang Liu
- Department of General Medicine, Affiliated Anqing First People's Hospital of Anhui Medical University, Anqing, Anhui, 246000, China
| |
Collapse
|
2
|
Rodriguez-Calienes A, Vivanco-Suarez J, Galecio-Castillo M, Zevallos CB, Farooqui M, Malaga M, Moran-Mariños C, Fanning NF, Algin O, Samaniego EA, Pabon B, Mouchtouris N, Altschul DJ, Jabbour P, Ortega-Gutierrez S. Use of the Woven EndoBridge Device for Sidewall Aneurysms: Systematic Review and Meta-analysis. AJNR Am J Neuroradiol 2023; 44:165-170. [PMID: 36635056 PMCID: PMC9891330 DOI: 10.3174/ajnr.a7766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2022] [Accepted: 12/18/2022] [Indexed: 01/13/2023]
Abstract
BACKGROUND The Woven EndoBridge device was originally approved to treat intracranial wide-neck saccular bifurcation aneurysms. Recent studies have suggested its use for the treatment of sidewall intracranial aneurysms with variable success. PURPOSE Our aim was to evaluate the safety and efficacy of the Woven EndoBridge device for sidewall aneurysms using a meta-analysis of the literature. DATA SOURCES We performed a systematic review of all studies including patients treated with the Woven EndoBridge device for sidewall aneurysms from inception until May 2022 on Scopus, EMBASE, MEDLINE, the Web of Science, and the Cochrane Central Register of Controlled Trials. STUDY SELECTION Ten studies were selected, and 285 patients with 288 sidewall aneurysms were included. DATA ANALYSIS A random-effects meta-analysis of proportions using a generalized linear mixed model was performed as appropriate. Statistical heterogeneity across studies was assessed with I2 statistics. DATA SYNTHESIS The adequate occlusion rate at last follow-up was 89% (95% CI, 81%-94%; I2, = 0%), the composite safety outcome was 8% (95% CI, 3%-17%; I2 = 34%), and the mortality rate was 2% (95% CI, 1%-7%; I2 = 0%). Aneurysm width (OR = 0.5; P = .03) was the only significant predictor of complete occlusion. LIMITATIONS Given the level of evidence, our results should be interpreted cautiously until confirmation from larger prospective studies is obtained. CONCLUSIONS The initial evidence evaluating the use of the Woven EndoBridge device for the treatment of wide-neck sidewall intracranial aneurysms has demonstrated high rates of adequate occlusion with low procedural complications. Our findings favor the consideration of the Woven EndoBridge device as an option for the treatment of sidewall aneurysms.
Collapse
Affiliation(s)
- A Rodriguez-Calienes
- From the Departments of Neurology (A.R.-C., J.V.-S., M.G.-C., C.B.Z., M.F., M.M.)
- Neuroscience, Clinical Effectiveness and Public Health Research Group (A.R.-C.), Universidad Científica del Sur, Lima, Peru
| | - J Vivanco-Suarez
- From the Departments of Neurology (A.R.-C., J.V.-S., M.G.-C., C.B.Z., M.F., M.M.)
| | - M Galecio-Castillo
- From the Departments of Neurology (A.R.-C., J.V.-S., M.G.-C., C.B.Z., M.F., M.M.)
| | - C B Zevallos
- From the Departments of Neurology (A.R.-C., J.V.-S., M.G.-C., C.B.Z., M.F., M.M.)
| | - M Farooqui
- From the Departments of Neurology (A.R.-C., J.V.-S., M.G.-C., C.B.Z., M.F., M.M.)
| | - M Malaga
- From the Departments of Neurology (A.R.-C., J.V.-S., M.G.-C., C.B.Z., M.F., M.M.)
| | - C Moran-Mariños
- Unidad de Investigación en Bibliometría (C.M.-M.), Universidad San Ignacio de Loyola, Lima, Peru
| | - N F Fanning
- Department of Neuroradiology (N.F.F.), Cork University Hospital, Cork, Ireland
| | - O Algin
- Department of Radiology (O.A.), Bilkent City Hospital, Ankara, Turkey
- National MR Research Center (O.A.), Bilkent University, Ankara, Turkey
- Radiology Department (O.A.), Medical Faculty, Yıldırım Beyazıt University, Ankara, Turkey
| | - E A Samaniego
- Neurology, Neurosurgery and Radiology (E.A.S., S.O.-G.), University of Iowa Hospitals and Clinics, Iowa City, Iowa
| | - B Pabon
- Department of Neurosurgery (B.P.), AngioTeam, Medellin, Colombia
| | - N Mouchtouris
- Department of Neurological Surgery (N.M., P.J.), Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
| | - D J Altschul
- Department of Neurological Surgery (D.J.A.), Montefiore Medical Center, Bronx, New York
| | - P Jabbour
- Department of Neurological Surgery (N.M., P.J.), Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
| | - S Ortega-Gutierrez
- Neurology, Neurosurgery and Radiology (E.A.S., S.O.-G.), University of Iowa Hospitals and Clinics, Iowa City, Iowa
| |
Collapse
|